Key Dates

Related Announcements

• December 05, 2023 - Omics Phenotypes Related to Down Syndrome for the INCLUDE Project (X01 Clinical Trial Not Allowed). See PAR-24-081. 

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) is participating, effective immediately, in PAR-24-081 "Omics Phenotypes Related to Down Syndrome for the INCLUDE Project (X01 Clinical Trial Not Allowed)". 

The following sections of PAR-24-081 have been updated (in bold italics) to reflect NHLBI participation in this Notice of Funding Opportunity.

Part 1. Overview Information

Components of Participating Organizations

Office of The Director, National Institutes of Health (OD)

National Human Genome Research Institute (NHGRI)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute on Deafness and Other Communication Disorders (NIDCD)

National Institute of Dental and Craniofacial Research (NIDCR)

National Heart, Lung, and Blood Institute (NHLBI)

Assistance Listing Number(s):93.865, 93.172, 93.121, 93.173, 93.837, 93.233, 93.838, 93.840, 93.839

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)

Charlene Schramm, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-402-3793
Email: [email protected]

Grants Management Contact(s)

Fatima Kamara
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-7916
Email: [email protected]

 All other aspects of the NOFO remain unchanged.

Inquiries

Please direct all inquiries to:

Charlene Schramm, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-402-3793
Email: [email protected]